{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:22:11Z","timestamp":1779916931063,"version":"3.53.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Kelowna Association of Radiation Oncology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12029-025-01228-6","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T04:14:17Z","timestamp":1744949657000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of Palliative Esophageal External Beam Radiation Therapy in Patients with Stent for Esophageal Cancer: A Retrospective Cohort Study"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9780-4006","authenticated-orcid":false,"given":"Emily","family":"Adams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3974-5504","authenticated-orcid":false,"given":"H\u00e9lo\u00efse","family":"Lavoie-Gagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4800-0723","authenticated-orcid":false,"given":"Farhana","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Humer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5636-604X","authenticated-orcid":false,"given":"Benjamin","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora A.","family":"Koulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7624-7128","authenticated-orcid":false,"given":"Siavash","family":"Atrchian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,18]]},"reference":[{"key":"1228_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.radonc.2020.05.015","volume":"147","author":"B Tinusz","year":"2020","unstructured":"Tinusz B, So\u00f3s A, Hegyi P, et al. Efficacy and safety of stenting and additional oncological treatment versus stenting alone in unresectable esophageal cancer: a meta-analysis and systematic review. Radiother Oncol. 2020;147:169\u201377. https:\/\/doi.org\/10.1016\/j.radonc.2020.05.015.","journal-title":"Radiother Oncol"},{"key":"1228_CR2","unstructured":"BC Cancer. Statistics by cancer type \u2013 esophagus. Bccancer.bc.ca. Published December 2019. Accessed April 30, 2023. http:\/\/www.bccancer.bc.ca\/statistics-and-reports-site\/Documents\/Cancer_Type_Esophagus_2017_20200327.pdf"},{"issue":"4","key":"1228_CR3","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S2468-1253(21)00004-2","volume":"6","author":"D Adamson","year":"2021","unstructured":"Adamson D, Byrne A, Porter C, et al. Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial. Lancet Gastroenterol Hepatol. 2021;6(4):292\u2013303. https:\/\/doi.org\/10.1016\/S2468-1253(21)00004-2.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"1228_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12029-010-9206-4","volume":"43","author":"A Javed","year":"2012","unstructured":"Javed A, Pal S, Dash NR, et al. Palliative stenting with or without radiotherapy for inoperable esophageal carcinoma: a randomized trial. J Gastrointest Cancer. 2012;43(1):63\u20139. https:\/\/doi.org\/10.1007\/s12029-010-9206-4.","journal-title":"J Gastrointest Cancer"},{"issue":"7","key":"1228_CR5","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1055\/a-1475-0063","volume":"53","author":"MCW Spaander","year":"2021","unstructured":"Spaander MCW, van der Bogt RD, Baron TH, et al. Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) guideline - update 2021. Endoscopy. 2021;53(7):751\u201362. https:\/\/doi.org\/10.1055\/a-1475-0063.","journal-title":"Endoscopy"},{"issue":"5","key":"1228_CR6","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/s0360-3016(03)00198-6","volume":"56","author":"Y Nishimura","year":"2003","unstructured":"Nishimura Y, Nagata K, Katano S, et al. Severe complications in advanced esophageal cancer treated with radiotherapy after intubation of esophageal stents: a questionnaire survey of the Japanese Society for Esophageal Diseases. Int J Radiat Oncol. 2003;56(5):1327\u201332. https:\/\/doi.org\/10.1016\/s0360-3016(03)00198-6.","journal-title":"Int J Radiat Oncol"},{"issue":"2","key":"1228_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae.","journal-title":"Ann Surg"},{"key":"1228_CR8","unstructured":"Rice TW, Kelsen D, Blackstone EH, et al. 2017 Esophagus and esophagogastric junction. In: AJCC Cancer Staging Manual. 8th ed. Springer Nature; 185\u2013202."},{"issue":"3","key":"1228_CR9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S1051-0443(07)61722-9","volume":"13","author":"HY Song","year":"2002","unstructured":"Song HY, Lee DH, Seo TS, et al. Retrievable covered nitinol stents: experiences in 108 patients with malignant esophageal strictures. J Vasc Interv Radiol. 2002;13(3):285\u201392. https:\/\/doi.org\/10.1016\/S1051-0443(07)61722-9.","journal-title":"J Vasc Interv Radiol"},{"issue":"13","key":"1228_CR10","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1245\/s10434-012-2459-3","volume":"19","author":"NM Rueth","year":"2012","unstructured":"Rueth NM, Shaw D, D\u2019Cunha J, Cho C, Maddaus MA, Andrade RS. Esophageal stenting and radiotherapy: a multimodal approach for the palliation of symptomatic malignant dysphagia. Ann Surg Oncol. 2012;19(13):4223\u20138. https:\/\/doi.org\/10.1245\/s10434-012-2459-3.","journal-title":"Ann Surg Oncol"},{"key":"1228_CR11","unstructured":"Guideline Resource Unit, Cancer Care Alberta. Esophageal Cancer: Clinical Practice Guideline GI-009 \u2013 Version 6. Albertahealthservices.ca. Published June 2021. Accessed January 31, 2023. https:\/\/www.albertahealthservices.ca\/assets\/info\/hp\/cancer\/if-hp-cancer-guide-gi009-esophageal.pdf"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01228-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-025-01228-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01228-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T04:14:22Z","timestamp":1744949662000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-025-01228-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1228"],"URL":"https:\/\/doi.org\/10.1007\/s12029-025-01228-6","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,18]]},"assertion":[{"value":"7 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received harmonized research ethics board approval from UBC BC Cancer Research Ethics Board and Interior Health Research Ethics Board (study number H20 -\u200901958). We received a waiver of patient consent for our retrospective chart review and all study procedures were performed in accordance with the 1964 Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"This study was granted a waiver of patient consent by the UBC BC Cancer and Interior Health Research Ethics Boards, so no patient consent is required for participation or publication. No identifying patient information is included in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate & Consent to Publish"}},{"value":"Dr. Theodora Koulis has received honoraria from Merck for a speaker presentation and has attended and lectured at the Canadian Breast Cancer Symposium. Dr. Benjamin Mou has received honoraria from AstraZeneca, Bristol Myers Squibb and Amgen. The remaining authors have declared no financial or non-financial interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"102"}}